The treatment of Gallstones & Malabsorption Syndrome with vitamins

Gallstones and Malabsorption Syndrome: Mitamins custom make quality formulas for the treatment of Gallstones & Malabsorption Syndrome with vitamins. A Gallstones & Malabsorption Syndrome formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Gallstones and Malabsorption Syndrome

  • Amount Per Serving
    % DV
    Vitamin C
    100
    mg
    167%
    Vitamin B6
    50
    mg
    2500%
    Folate
    400
    mcg
    100%
    Vitamin B12
    125
    mcg
    2083%
    Choline Bitartrate
    50
    mg
    *
    Inositol
    50
    mg
    *
    Lactobacillus acidolphilus
    100
    mg
    *
    Omega - 3 Fatty Acids
    50
    mg
    *
  • Amount Per Serving
    % DV
    Lecithin
    50
    mg
    *
    Milk Thistle Extract
    50
    mg
    *
    L-Methionine
    100
    mg
    *
    Taurine
    100
    mg
    *
    Dandelion Extract
    50
    mg
    *
    Peppermint Extract
    50
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Gallstones and Malabsorption Syndrome
Serving Size:4-5

Gallstones and Malabsorption Syndrome Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Lupus Foundation Of America Statement On Results For Clinical Study Of CellCept(R) Released By Aspreva Pharmaceutical Company
The Lupus Foundation of America, Inc. and more than 1.5 million Americans with lupus have been awaiting the preliminary findings of the Phase III clinical trials for CellCept(R), a potential treatment for lupus kidney disease being tested by Aspreva Pharmaceutical Company.
Potential New Therapy For One Of The World's Leading Causes Of Blindness
An inflammatory eye condition that is one of the world's leading causes of blindness could be treated much more effectively and easily thanks to a new discovery here.In experiments with laboratory rats, scientists at the University of Texas Medical Branch at Galveston have developed a potential new therapy for uveitis -- the inflammation of the uvea, a layer of tissue that lies just below the outer surface of the eyeball and includes the iris.
This information concerning the support of Gallstones and Malabsorption Syndrome treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments